The Current Ratio as of November 2025 (TTM) for Turning Point Therapeutics, Inc. (TPTX) is 21.08

According to Turning Point Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 21.08. This represents a change of -1.14% compared to the average of 21.32 of the last 4 quarters.

Turning Point Therapeutics, Inc. (TPTX) Historical Current Ratio (quarterly & annually)

How has TPTX Current Ratio performed in the past?

The mean historical Current Ratio of Turning Point Therapeutics, Inc. over the last ten years is 25.23. The current 21.08 Current Ratio has changed 8.25% with respect to the historical average. Over the past ten years (40 quarters), TPTX's Current Ratio was at its highest in in the June 2020 quarter at 62.79. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Turning Point Therapeutics, Inc. (TPTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Turning Point Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Turning Point Therapeutics, Inc. (TPTX) Average Current Ratio

How has TPTX Current Ratio performed in the past?

The current Current Ratio of Turning Point Therapeutics, Inc. (TPTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Turning Point Therapeutics, Inc. (TPTX) Current Ratio vs. Peers

How is TPTX’s Current Ratio compared to its peers?

Turning Point Therapeutics, Inc.’s Current Ratio is greater than SpringWorks Therapeutics, Inc. (4.33), greater than Mirati Therapeutics, Inc. (6.96), greater than CymaBay Therapeutics, Inc. (10.96), less than RayzeBio, Inc. Common Stock (28.69), greater than Opthea Limited (2.94), less than Morphic Holding, Inc. (28.94), greater than MorphoSys AG (3.08), greater than Chinook Therapeutics, Inc. (7.59), greater than Myovant Sciences Ltd. (1.95), greater than Alpine Immune Sciences, Inc. (7.86),

Build a custom stock screener for Turning Point Therapeutics, Inc. (TPTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Turning Point Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Turning Point Therapeutics, Inc. (TPTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Turning Point Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.